{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:34:46Z","timestamp":1791178486652,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>Because successful outcome after transplantation seems to depend in acute myeloid leukaemia (AML) and in chronic phase chronic myeloid leukaemia (CML) on disease status at the time of transplantation, we investigated whether FLAN (fludarabine, cytosine arabinoside, mitoxantrone) induction before allogeneic stem cell transplantation (allo\u2010SCT) may be useful in blastic phase (BP)\u2010CML. Twenty patients with BP\u2010CML were studied: 10 patients received FLAN induction chemotherapy before proceeding to early allo\u2010SCT, whereas 10 patients were submitted to bone marrow transplantation (BMT) without remission induction. Eight out of 10 (80%) patients achieved second chronic phase after one course of therapy with FLAN and seven patients (six in second chronic phase and one with partial response) were then submitted to allo\u2010SCT. Of the six patients transplanted in the second chronic phase, all achieved molecular remission, four are still in second chronic phase, with intervals ranging from 10 to 54\u2003months, whereas one patient died from infection having relapsed 14\u2003months after SCT and one died of transplant\u2010related complications in the second chronic phase. Mean durations of second chronic phase and survival after allo\u2010SCT were both significantly longer than in the group of 10 BP\u2010CML patients submitted to allo\u2010SCT without FLAN remission induction treatment [22\u00b74 (range 1\u201361) vs. 3\u00b75\u2003months (range 1\u201310) with FLAN and 22\u00b77 (range 2\u201361) vs. 6\u00b74 (range 1\u201316) months without FLAN]. We conclude that FLAN induction therapy followed by early allo\u2010SCT appears to be effective in the treatment of BP\u2010CML and could provide a curative possibility for BP\u2010CML patients.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02060.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:25:35Z","timestamp":1047363935000},"page":"722-728","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia"],"prefix":"10.1111","volume":"109","author":[{"given":"Giuseppe","family":"Visani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianantonio","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Malagola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Stanzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sante","family":"Tura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320171"},{"key":"e_1_2_6_3_1","first-page":"517","article-title":"Therapy of blastic phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine","volume":"5","author":"Carella A.M.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood.V93.5.1534","article-title":"Autografting with Philadelphia chromosome\u2010negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia","volume":"93","author":"Carella A.M.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_5_1","first-page":"513","article-title":"High efficiency of fludarabine containing therapy (FLAN\/FLANG) in poor risk acute myeloid leukemia","volume":"81","author":"Clavio M.","year":"1996","journal-title":"Haematologica"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30493-3"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90122-6"},{"key":"e_1_2_6_8_1","first-page":"21","article-title":"High remission rate, short remission duration in patients with refractory\u2010anemia excess blasts (RAEB) in transformation (RAEBt) given acute myelogenous leukemia (AML)\u2010type chemotherapy in combination with granulocyte\u2010CSF (G\u2010CSF)","volume":"1","author":"Estey E.","year":"1995","journal-title":"Cytokines and Molecular Therapy"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.1993.11.1.116","article-title":"Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy","volume":"11","author":"Ghandi V.","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.1993.11.6.1055","article-title":"Effect of prior IFN alpha therapy on the outcome of allogeneic bone marrow transplantation in chronic myelogenous leukemia","volume":"11","author":"Giralt S.A.","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_11_1","first-page":"74","article-title":"Use of transplants in chronic myeloid leukaemia","volume":"10","author":"Goldman J.M.","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V82.7.2235.2235","article-title":"Choice of pretransplant treatment and timing of transplants of chronic myelogenous leukemia in chronic phase","volume":"82","author":"Goldman J.M.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_13_1","first-page":"682a","article-title":"Effect of prior IFN therapy on outcome of HLA\u2010identical sibling bone marrow transplant for chronic myelogenous leukemia (CML) in first chronic phase","volume":"88","author":"Horowitz M.M.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1016\/S0021-9258(17)46267-3","article-title":"Incorporation of 9\u2010b\u2010D arabinofuranosyl\u20102\u2010fluoroadenine into DNA and its chain termination: effect on DNA synthesis","volume":"265","author":"Huang P.","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050239"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910615)67:12<2959::AID-CNCR2820671203>3.0.CO;2-T"},{"key":"e_1_2_6_17_1","first-page":"10","article-title":"Treatment of chronic myelogenous leukemia (CML) in accelerated and blastic phases with daunorubicin, high dose cytosine arabinoside and granulocyte\u2013macrophage colony stimulating factor","volume":"18","author":"Kantarjian H.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_18_1","first-page":"57","article-title":"High dose of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia","volume":"14","author":"Kantarjian H.M.","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830180304"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401066"},{"key":"e_1_2_6_22_1","first-page":"775","article-title":"Results with high\u2010dose chemotherapy and unpurged stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience","volume":"17","author":"Khouri I.F.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450403"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V92.2.394","article-title":"Association between pretransplant interferon\u2010\u03b1 and outcome after unrelated donor marrow transplantation for chronic myeloid leukemia in chronic phase","volume":"92","author":"Morton A.J.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709068275"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4763281.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_6_28_1","first-page":"19","article-title":"Toxicity, metabolism and incorporation into DNA and RNA of arabinosil\u20102\u2010fluoroadenine (F\u2010ara\u2010A)","volume":"26","author":"Plunkett W.","year":"1985","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_6_29_1","first-page":"2349","article-title":"Comparison of the toxicity and metabolism of 9\u2010b\u2010D arabinofuranosyl\u20102\u2010fluoroadenine and 9\u2010b\u2010D arabinofuranosyladenine in human lymphoblastoid cells","volume":"40","author":"Plunkett W.","year":"1980","journal-title":"Cancer Research"},{"key":"e_1_2_6_30_1","first-page":"992","article-title":"A cell\u2010culture model for the treatment of acute myeloblastic\u2010leukemia with fludarabine and cytosine arabinoside","volume":"7","author":"Rayappa C.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V81.1.143.143","article-title":"Induction of apoptotic cell death in chronic lymphocytic leukemia by 2\u2010chloro\u20102\u2032deoxyadenosine and 9\u2010b\u2010D arabinofuranosyl\u20102\u2010fluoroadenine","volume":"81","author":"Robertson L.E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_32_1","article-title":"\u03b1\u2010IFN treatment for CML patients before allogeneic BMT: any influence on transplant outcome?","volume":"17","author":"Rosti G.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high risk acute leukemia: the effect of leukemic burden, donor HLA\u2010matching and marrow cells dose","volume":"89","author":"Sierra J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_34_1","first-page":"5953","article-title":"Fludarabine phosphate (NCS 312878) infusions for the treatment of acute leukemia: phase 1 and neuropathological study","volume":"46","author":"Spriggs D.","year":"1986","journal-title":"Cancer Research"},{"key":"e_1_2_6_35_1","first-page":"474","article-title":"In vitro activity of 9\u2010b\u2010D arabinofuranosyl\u20102\u2010fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reduction from HeLa cells","volume":"21","author":"Tseng W.C.","year":"1984","journal-title":"Molecular Pharmacology"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403243301204"},{"key":"e_1_2_6_37_1","first-page":"1842","article-title":"FLAG (fludarabine plus high\u2010dose cytarabine plus G\u2010CSF) \u2013 an effective and tolerable protocol for the treatment of poor\u2010risk acute myeloid leukemias","volume":"8","author":"Visani G.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04749.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02060.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02060.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02060.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T10:01:41Z","timestamp":1698573701000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02060.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02060.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02060.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}